Next Pharma Revenue

Biotechnology Research • Richmond Hill, Ontario, Canada • 1-10 Employees

Next Pharma revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Next Pharma

Arsha Moshiri

Executive Vice President

Company overview

Headquarters	1 Jenny Thompson Crt, Richmond Hill, Ontario L4S 0E7, CA
Website	nextpharmainc.com
NAICS	541714
SIC	738
Keywords	Reliable, Fast And Cost-Effective Aabh Detection Tests, Highly Accurate, Which Can Be Used For Early Diagnosis
Founded	2016
Employees	1-10

About Next Pharma

Next Pharma Inc. (NPI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis, treatment and monitoring the recurrence of cancer in addition to treat bacterial, fungal and viral infections including HCV infection. Next Pharma’s novel products are: a blood test that can measure the blood level of Aspartyl (Asparaginyl) β-Hydroxylase (AABH) and two Peptide Based Drug candidates (cLF-671 and cLF-672) that should treat HCV and different types of Cancer. AABH (a novel cancer bio-marker), cLF-671 and cLF-672 (two novel Therapeutic engineered peptides) are the products which make the foundation of our breakthrough technology. Next Pharma, is closing its Series C financing for a total of $14 million (Lead Director Kiarash Moshiri) and will be in a strong position to complete the animal study of its lead anti-Cancer and anti-HCV Peptide Based Drugs, as well as pursuing its late-stage pre-clinical candidates toward integrated cancer management. Next Pharma’s lead Peptide Based Anti-Cancer and Anti-HCVDrug candidates, and it’s late-stage pipeline of pre-clinical candidates, as well as it’s cancer diagnostic products, constitute Next Pharma’s integrated cancer management program. Relaying on our hard working in-house senior scientists and our worlds class collaborators, we strongly believe that we will pursue this extraordinary program. Beyond our lead Peptide Based Drug candidates and AABH based Early diagnostic cancer tests, our early-stage next pipeline of products consists of Radio-immuno-imaging to determine the site and size of tumor. I this pipeline of products, we would use a radioisotope-labeled, all human, anti-AABH antibody and radio-immunotherapy using high-energy, short-lived alpha or beta emitting radioisotopes bound to the anti-AABH antibody to specifically target cancer cells.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Funding Data

Next Pharma has never raised funding before.

Frequently asked questions

Next Pharma is located in Richmond Hill, Ontario, CA.

Next Pharma generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Next Pharma has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Next Pharma was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Next Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Next Pharma

Arsha Moshiri

Executive Vice President

4.8

40,000 users